US Patent Issued to LABORATORIOS FARMACEUTICOS ROVI on June 3 for "Method of treating acute exacerbation of schizophrenia with long-acting injectable depot composition" (Spanish Inventors)

ALEXANDRIA, Va., June 4 -- United States Patent no. 12,318,387, issued on June 3, was assigned to LABORATORIOS FARMACEUTICOS ROVI S.A. (Madrid).

"Method of treating acute exacerbation of schizophrenia with long-acting injectable depot composition" was invented by Ibon Gutierro Aduriz (Madrid) and Javier Martinez Gonzalez (Madrid).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of treating an episode of acute exacerbation of schizophrenia by intramuscular administration of a long-acting injectable depot composition containing risperidone is provided. The method provides a substantial reduction in PANSS (both positive and negative scales) and CGI-S scores within about eight days after administration of ...